Publisher： Bentham Science Publishers
E-ISSN： 1875-628x|6|1|13-13
ISSN： 1570-1808
Source： Letters in Drug Design & Discovery, Vol.6, Iss.1, 2009-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Buprenorphine maintenance treatment has become a major intervention in the care and treatment of drug dependence in Europe. Still little is known about sexual behaviour and sexual dysfunction especially under buprenorphine or methadone maintenance treatment. Our study aimed to evaluate patterns of sexual behaviour and dysfunction prevalence within buprenorphine and methadone maintenance treatment. Significant differences between both groups could be observed regarding sexual excitation disturbances and ability to orgasm. 33.3% of the methadone-maintained group showed significantly higher sexual excitation disturbances (p = 0.006). Future studies of sexual dysfunction in opioid-treated persons should examine the potential benefits of dose reduction, androgen replacement, and choice of opioid.
Related content
Methadone Maintenance and Male Sexual Dysfunction
By Brown Randy Balousek Stacey Mundt Marlon Fleming Michael
Journal of Addictive Diseases, Vol. 24, Iss. 2, 2005-03 ,pp. :
Access to resources
Recommend
By Loeber Sabine Kniest Anja Diehl Alexander Mann Karl Croissant Bernhard
The American Journal of Drug and Alcohol Abuse, Vol. 34, Iss. 5, 2008-09 ,pp. :